Ethyl glucuronide for detecting alcohol lapses in patients with an alcohol use disorder.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21817916.
- Also identified by DOI 10.1097/ADM.0b013e3182249b93.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Urine ethyl glucuronide (EtG) was screened in 75 patients during a hospital-based treatment for an alcohol use disorder. During follow-up, EtG was detected in 35 (14.6%) of the 239 urine samples. Positive screens were found in 22 patients (29%), of whom nine were outpatients (39.1% of all outpatients) and 13 inpatients (25.0% of all inpatients). Of the 22 patients with positive EtG, five (22%) also gave a positive breath alcohol test and 10 (45.5%) reported recent alcohol consumption; 12 (54.5%) gave a negative breath alcohol test and declared no alcohol lapse. Ethyl glucuronide has been found useful in detecting covered lapses.
Medical subject headings
- Alcoholism
- Biomarkers
- Glucuronates
- Temperance